Stay updated on EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page.

Latest updates to the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAccess to the study record is blocked by a 403 Forbidden page, replacing the previous study details with an error screen. This indicates an access restriction rather than an update to the trial content.SummaryDifference21%

- Check36 days agoChange DetectedPage revision updated from v3.6.5 to v3.6.6, indicating a maintenance/patch update to the page rendering.SummaryDifference0.1%

- Check57 days agoChange DetectedPage revision updated from v3.6.4 to v3.6.5, signaling an update to the site's documentation/UI. The update does not modify the study content, eligibility criteria, or how a user interacts with the page.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page revision has been updated from v3.6.3 to v3.6.4, reflecting a minor update to the page’s metadata and/or content.SummaryDifference0.0%

- Check93 days agoChange DetectedThe site revision tag changed from v3.6.2 to v3.6.3, indicating a minor software update to the page. This change does not alter study content or key functionality.SummaryDifference0.0%

- Check100 days agoChange DetectedThe page shows Revision: v3.6.2, replacing the previous Revision: v3.6.0. This indicates a software or template update rather than a change to study details.SummaryDifference0.0%

Stay in the know with updates to EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page.